| | Identification | Back Directory |  | [Name] 
 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodiuM salt)
 |  | [CAS] 
 200880-42-8
 |  | [Synonyms] 
 18:0 PG
 DSPG Sodium Salt
 L-α-Phosphatidyl-DL-glycerol, distearoyl
 1,2-Distearoyl-sn-glycero-3-PG (sodium salt)
 1,2-Distearoyl-sn-glycero-3-phosphorylglycerol sodium salt
 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodiuM salt)
 Sodium (2R)-2,3-Bis(stearoyloxy)propyl 2,3-Dihydroxypropyl Phosphate
 1,2-Dioctadecanoyl-sn-glycero-3-phospho-(1′-rac-glycerol) sodium salt
 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)(DSPG)
 sodium [(2R)-2,3-bis(1-oxooctadecoxy)propyl] 2,3-dihydroxypropyl phosphate
 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) (SODIUM SALT);18:0 PG;DSPG;PG(18:0/18:0)
 Octadecanoic acid (1R)-1-[[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester monosodium salt
 1,2-Dioctadecanoyl-sn-glycero-3-phospho-(1′-rac-glycerol) sodium salt, 1,2-Distearoyl-sn-glycero-3-phosphoglycerol, L -α-Phosphatidyl-DL-glycerol, distearoyl, DSPG-Na, Octadecanoic acid (1R)-1-[[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-1,2-eth
 |  | [Molecular Formula] 
 C81H159Na2O16P
 |  | [MDL Number] 
 MFCD00077290
 |  | [MOL File] 
 200880-42-8.mol
 |  | [Molecular Weight] 
 1466.07
 | 
 | Chemical Properties | Back Directory |  | [storage temp. ] 
 -20°C
 |  | [solubility ] 
 Chloroform:Methanol:Water = 2:1:0.1 (Very Slightly)
 |  | [form ] 
 Solid
 |  | [color ] 
 White to Off-White
 |  | [Stability:] 
 Hygroscopic
 | 
 | Hazard Information | Back Directory |  | [Description] 
 DSPG, also known as 1,2-Distearoyl-sn-glycero-3-phosphoglycerol, is a phospholipid molecule with phosphate polar head connected to two non-polar lipid (stearic acid) by a glycerol molecule. In water, the molecule can orient itself into lipid bilayer and can be used for drug encapsulation, such as drug loaded liposomes or nanoparticles.
 |  | [Uses] 
 1,2-Distearoyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt is used to prepare polyethyleneglycol-modified liposomal doxorubicin for therapies against drug resistant tumors. It is also used in the PEGylated liposomal drug formulation of the anti-cancer agent oxaliplatin.
 | 
 |  |